Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial
一项开放标签、单盲、前瞻性随机对照试验，旨在评估6个月二十碳五烯酸（EPA）治疗对新诊断的伴有冠状动脉疾病的糖代谢异常患者餐后高血糖、高脂血症、胰岛素分泌能力及伴随内皮功能障碍的影响。
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-016-0437-y
Sawada, Takahiro; Tsubata, Hideo; Hashimoto, Naoko; Takabe, Michinori; Miyata, Taishi; Aoki, Kosuke; Yamashita, Soichiro; Oishi, Shogo; Osue, Tsuyoshi; Yokoi, Kiminobu; Tsukishiro, Yasue; Onishi, Tetsuari; Shimane, Akira; Taniguchi, Yasuyo; Yasaka, Yoshinori; Ohara, Takeshi; Kawai, Hiroya; Yokoyama, Mitsuhiro
